SPGL008
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SPGL008, covering 2026-02-09 to 2026-03-03. Get the full timeline:
Most recent: Clinical Trial Update: The Study is to Evaluate the Safety and Tolerability of SPGL008 Alone or in Combination With BCG in the Patients With NMIBC, and to Determine the RP2D of SPGL008 Alone or in Combination With BCG.To Evaluate the Preliminary Efficacy of SPGL008 Alone or in Combination With BCG. [Phase 1, Phase 2]